Why the two are so tightly linked
Roughly nine in ten people living with type 2 diabetes also live with overweight or obesity. That overlap is so consistent that researchers coined a term for it — diabesity — to describe what is less a coincidence than a shared underlying process.
Understanding that process is genuinely useful, because it explains something that surprises a lot of people: type 2 diabetes is not simply a one-way street. The same mechanism that drives it can, in many cases, run in reverse.
What actually connects them: insulin resistance
Insulin is the hormone that lets your cells take glucose out of the bloodstream and use it. Insulin resistance is what happens when those cells stop responding to it properly. The pancreas compensates by producing more, blood insulin levels climb, and for a while blood glucose stays normal. Type 2 diabetes appears when the pancreas can no longer keep up.
Excess body fat drives that resistance through several routes at once. Fat tissue is not inert storage — it is metabolically active, releasing free fatty acids, hormones and signalling molecules into circulation. In excess it increases pro-inflammatory cytokines, alters the balance of adipokines, and interferes directly with insulin signalling inside cells.
Where the fat sits matters more than what you weigh
This is the part most often missed, and it is the most practically important thing on this page.
Insulin resistance tracks visceral fat — the fat packed around the internal organs — largely independently of BMI. Visceral fat drains directly into the portal circulation feeding the liver, and it is far more metabolically disruptive than the subcutaneous fat you can pinch.
Two consequences follow. Someone can sit within a “normal” BMI and still carry enough visceral fat to be meaningfully insulin resistant. And someone with a high BMI who carries proportionally more subcutaneous fat may have better metabolic markers than their weight suggests. It is why waist measurement adds real information that the scales do not, and why BMI alone is a blunt instrument for judging metabolic health.
The loop that makes it self-reinforcing
Insulin is a storage hormone. When insulin levels are persistently high, the body is biased toward storing fat and away from releasing it. So insulin resistance makes weight harder to lose, and the additional weight deepens the insulin resistance.
Anyone who has tried to lose weight while already insulin resistant has felt this loop from the inside, usually without a name for it. It is also why “just eat less” advice fails so many people: the hormonal environment is actively working against the instruction.
See how the claim works →Expert supervised weight loss.
We help you lose weight consistently, safely and for good.
The loop can run the other way
Because the relationship is mechanical rather than moral, reducing the driver tends to move the outcome. Meaningful weight loss — particularly visceral fat loss — improves insulin sensitivity, and improved insulin sensitivity makes further weight loss easier. The same loop, reversed.
In a proportion of cases, sustained weight loss can bring blood glucose back into the non-diabetic range without medication, an outcome usually described as remission rather than cure. The distinction matters: remission is real and well documented, but it is not permanent by default. Weight regain can bring type 2 diabetes back, which is why maintenance is treated as part of the treatment rather than as an afterthought.
Remission is not achievable for everyone. It is generally more likely earlier in the course of the condition, and it depends on how much insulin-producing capacity remains. That is a conversation for the doctor managing your diabetes, not something to judge from a website — but it is a legitimate question to raise, and many people never think to ask it.
What tends to shift the picture
None of the following is a treatment plan, and none of it replaces the care of whoever manages your diabetes. But the levers that move insulin resistance are reasonably consistent.
- Losing visceral fat specifically. Waist circumference is often the more informative measure to track, and it frequently improves before the scales move much.
- Resistance training. Muscle is the largest site of glucose disposal in the body, so building and keeping it improves glucose handling directly — independently of weight change.
- Any regular movement. Muscle contraction pulls glucose from the blood through a route that does not require insulin at all. A walk after eating is not a token gesture.
- Sleep. Short sleep measurably worsens insulin sensitivity within days. It is the most commonly ignored variable on this list.
- Protein and fibre first. Not a diet rule so much as a practical way to blunt the glucose response of a meal and stay full longer.
Where GLP-1 medication fits — and an Irish quirk worth knowing
GLP-1 medicines are relevant to this page precisely because they sit at the junction of the two conditions. They were developed for type 2 diabetes, where they improve glucose control, and their effect on weight is what later made them famous. Tirzepatide adds a second mechanism, GIP, alongside GLP-1.
Which brings us to a genuine oddity of the Irish system. The same medicines are funded very differently depending on which end of the loop you are treating. Ozempic and Mounjaro are reimbursed through the Long Term Illness scheme for type 2 diabetes — but treatment for weight management, which is the upstream driver of that diabetes, is almost entirely private-pay. Wegovy and Mounjaro are not reimbursed by the State for weight loss, and only Saxenda is, under a narrow HSE Managed Access Protocol.
So the State covers the destination and not the road to it. We set out the current funding position in detail in will Mounjaro be free on the HSE?, and how the four medicines differ in Mounjaro vs Ozempic vs Wegovy vs Saxenda.
If you already have type 2 diabetes, your care belongs with your GP or diabetes team — this is not a page about switching that. If you do not have diabetes but recognise the pattern described here, that is worth raising with a doctor while it is still upstream.
Diabetes and obesity FAQs
Does obesity cause type 2 diabetes?
It is the single largest modifiable risk factor, acting mainly through insulin resistance, and around 90% of people with type 2 diabetes also live with overweight or obesity. It is not the only factor — genetics, ethnicity, age and family history all contribute, and some people develop type 2 diabetes without obesity.
Can type 2 diabetes be reversed by losing weight?
Sustained weight loss can bring blood glucose into the non-diabetic range in a proportion of people, which is described as remission rather than cure. It is more likely earlier in the condition, is not achievable for everyone, and can be lost if weight is regained. Whether it is realistic for you is a question for the doctor managing your diabetes.
Why does belly fat matter more than overall weight?
Visceral fat — the fat around the internal organs — is metabolically active and drains directly to the liver, so insulin resistance tracks it largely independently of BMI. Waist measurement therefore adds information the scales miss.
Can you be insulin resistant at a normal weight?
Yes. Because the relationship follows visceral fat rather than total weight, someone within a normal BMI can carry enough of it to be meaningfully insulin resistant.
Are GLP-1 medications covered for diabetes in Ireland?
Ozempic and Mounjaro are reimbursed under the Long Term Illness scheme for type 2 diabetes. Treatment for weight management is a separate matter and largely private-pay: Wegovy and Mounjaro are not State-reimbursed for weight loss, and Saxenda only under a restricted HSE protocol.
Does losing weight always improve blood sugar?
Weight loss generally improves insulin sensitivity, but the size of the effect varies with how much visceral fat is lost, how long the condition has been present and individual factors. Improvement is common; guarantees are not available.
